Hisada Yohei, Mackman Nigel
Division of Hematology and Oncology, Thrombosis and Hemostasis Program Department of Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina.
Department of Pathology and Laboratory Medicine University of North Carolina at Chapel Hill Chapel Hill North Carolina.
Res Pract Thromb Haemost. 2018 Nov 20;3(1):44-48. doi: 10.1002/rth2.12165. eCollection 2019 Jan.
Tissue factor (TF) is the cellular receptor for plasma factor (F) VII/FVIIa and triggers blood coagulation. Extracellular vesicles (EVs) are small membrane vesicles that are released from activated cells and tumor cells. Different cell types, including activated monocytes and tumors cells release TF-positive EVs into the circulation. We developed an assay to measure levels of TF activity in EVs isolated from human plasma samples. We and others have used this assay to demonstrate increased levels of EV TF activity in a variety of diseases associated with thrombosis, including cancer. These studies suggest that EV TF can be used as a biomarker of thrombotic risk. The strength of this laboratory assay is that it is relatively sensitive and specific. However, the limitations of the assay are that it is labor intensive and the coefficient of variation is too high for it to be used as a clinical assay.
组织因子(TF)是血浆因子(F)VII/FVIIa的细胞受体,可触发血液凝固。细胞外囊泡(EVs)是从活化细胞和肿瘤细胞释放的小膜囊泡。包括活化单核细胞和肿瘤细胞在内的不同细胞类型会将TF阳性的EVs释放到循环中。我们开发了一种检测方法来测量从人血浆样本中分离出的EVs中的TF活性水平。我们和其他人已使用该检测方法证明,在包括癌症在内的多种与血栓形成相关的疾病中,EV TF活性水平升高。这些研究表明,EV TF可作为血栓形成风险的生物标志物。该实验室检测方法的优点是相对灵敏且特异。然而,该检测方法的局限性在于它劳动强度大,变异系数过高,无法用作临床检测。